Your session is about to expire
← Back to Search
Normothermic Machine Perfusion (NMP) for Liver Transplant
N/A
Waitlist Available
Research Sponsored by OrganOx Ltd.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Study Summary
This trial will continue to collect data on effectiveness and safety to support the goals of the original study.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Incidence of Early Allograft Dysfunction (EAD)
Secondary outcome measures
Incidence of Biliary Investigations/Interventions
Incidence of Ischemia-reperfusion Injury Via Analysis of Post-reperfusion Biopsies
Incidence of Primary Non-function
+14 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Normothermic Machine Perfusion (NMP)Experimental Treatment1 Intervention
Following the routine retrieval procedure of the liver, it will be placed on the OrganOx metra for Normothermic Machine Perfusion (NMP) for transport per the Investigational Plan and the Instructions for Use.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Normothermic Machine Perfusion (NMP)
2016
N/A
~270
Find a Location
Who is running the clinical trial?
North American Science Associates (NAMSA)UNKNOWN
2 Previous Clinical Trials
436 Total Patients Enrolled
OrganOx Ltd.Lead Sponsor
3 Previous Clinical Trials
607 Total Patients Enrolled
North American Science Associates Ltd.NETWORK
3 Previous Clinical Trials
451 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You need help breathing with a machine, support for your heart, or a machine to filter your blood.
Research Study Groups:
This trial has the following groups:- Group 1: Normothermic Machine Perfusion (NMP)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger